What the 'Pathway Approach' Can Do to Improve Health Outcomes, Reduce Testing Delays For Cancer Care
Dr. Yuri Fesko of Quest Diagnostics says the "pathways approach" helped one health system speed the time between diagnosis and targeted treatment for lung cancer by as much as a month for some patients. This is the second part of a three-part video series.
Editor of Managed Healthcare Executive, Briana Contreras, speaks with Oncologist and Vice President of Medical Affairs at Quest Diagnostics, Dr. Yuri Fesko, about why shortening the gap of time it takes to receive a cancer diagnosis and getting the treatment for it is critical to ensuring better patient outcomes. Dr. Fesko also shared steps hospitals, health systems and physicians can take now to reduce testing delays, improve outcomes and lower costs of care. These steps include using an innovative “pathways” approach that helped one health system speed the time between diagnosis and targeted treatment for lung cancer by as much as a month for some patients.
Verastem Begins Submission for Ovarian Cancer Combination
May 24th 2024Verastem is studying the combination of avutometinib and defactinib to treat low-grade serous ovarian cancer in patients with KRAS-mutations. The company plans to complete the new drug application in the second half of this year.
Read More
Using the 'Pathway' Approach to Shorten the Time Between Cancer Diagnosis and Treatment
November 16th 2022In this episode of Tuning In to the C-Suite, Briana Contreras, editor with Managed Healthcare Executive spoke with Dr. Yuri Fesko, oncologist and vice president of Medical Affairs at Quest Diagnostics. In the conversation, Dr. Fesko addressed the ongoing issue of long gaps of times between receiving a diagnosis for a type of cancer and finally getting the treatment for it. Dr. Fesko shared the benefits a number of sectors receive when treating patients sooner and the steps to get there.
Listen
